- You are here: Home
- Services
- Drug Toxicity Services
- Endocrine Disruption Screening Assay
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Endocrine Disruption Screening Assay
- Service Details
- Features
- FAQ
- Explore Other Options
Endocrine Disrupting Chemicals (EDCs) are exogenous chemical substances that interfere with the endocrine systems of humans and animals, potentially causing adverse effects on reproduction, development, metabolism, and brain function. EDCs include natural oestrogens, phytoestrogens, fungi oestrogens, synthetic oestrogens and other pollutants in the environment. Examples are Bisphenol A (BPA) and Nonylphenol, ubiquitous in plastics, pesticides, household items and the environment. These substances are also able to accumulate easily and can persist for many years, so that they are impossible to detoxify after they've made their way up the food chain. EDCs can enter the atmosphere via various sources such as incineration, industrial waste, and pesticide emissions, then accumulate in air, water, soil and living organisms, where they end up as ubiquitous contaminants, posing a serious risk. They are highly studied in the causes of infertility, cancer and diabetes.
The scientific and regulatory communities have recently increased attention to the risks of such chemicals, calling for their sources to be controlled and monitored. Creative Bioarray provides the specialized "Endocrine Disruption Screening Assay" service to assist clients in properly diagnosing and evaluating endocrine disruption risks. The service focuses on evaluations of chemical influences on the endocrine system through high-throughput screening and bioinformatics data, including chemicals, pharmaceuticals, and environmental contaminants. We use OECD-standardized in vitro and in vivo assays to make the data credible and scientifically valid, supporting our customers' research and development decisions.
According to the revised framework by the OECD, endocrine disruption assessment is categorized into five levels:
- Level 1 testing primarily involves reviewing existing data and non-testing information to preliminarily determine a chemical's potential as an endocrine disruptor.
- Level 2 testing offers direct insights into a chemical's effects on specific endocrine receptors through in vitro assays.
- Level 3 testing is in vivo studies in animal models to understand how chemicals impact endocrine mechanisms or pathways.
- Level 4 testing is in vivo evaluations in animal models, assessing adverse effects on endocrine-related endpoints, such as reproductive and developmental abnormalities.
- Level 5 testing is lifetime studies in animal models to provide comprehensive data on how chemicals affect endocrine systems across different life stages.
Creative Bioarray Offers a Comprehensive Endocrine Disruption Screening Assay, Including but not Limited to:
- In vitro tests:
Estrogen Receptor (ER) Transactivation
Androgen Receptor (AR) Transactivation
Androgen Receptor (AR) Modulation
Estrogen Receptor-alpha (ER-α) Binding
Estrogen Receptor beta (ER-β) Binding
Androgen Receptor (AR) Binding
Steroidogenesis
Aromatase Assay
- In vivo tests:
Short-term fish reproduction assays
Amphibian metamorphosis assays
Uterotrophic assays in rodents
Hershberger assays in rats
Peri-pubertal male and female assays
Repeated-dose toxicity studies
Two-generation reproductive toxicity studies
Extended one-generation reproductive toxicity studies
Service Features:
- Creative Bioarray assembles a dedicated expert team around your endocrine disruption testing needs to create a specialized plan.
- We possess a complete set of in vitro and in vivo testing systems, delivering economically efficient and rigorously scientific characterizations of substances' endocrine disruption potential.
- Our endocrine disruption screening assay strictly complies with OECD and EPA guidelines, ensuring international recognition and comparability of results.
FAQ
1. What are Endocrine Disruptors?
Endocrine Disruptors (EDCs), also known as environmental hormones, are chemicals that interfere with the normal functions of the endocrine system. They are present in the environment and can disrupt every aspect of endocrine regulation, leading to abnormal effects. Common EDCs include various organic compounds, heavy metals, and certain hormones, as well as plastic stabilizers and pesticides.
2. Why conduct Endocrine Disruption Screening?
EDCs can cause significant disruptions, altering cellular, organ, and physiological functions, adversely affecting human health. Screening helps identify and mitigate these potential threats, guiding manufacturers towards safer alternatives and minimizing environmental impact.
3. What happens if a substance is identified as an endocrine disruptor?
Upon positive initial screening, further advanced risk assessment tests are recommended to elucidate the mechanisms and potential health impacts, along with risk management advisories.
4. How long does endocrine disruptor screening typically take?
The duration depends on test complexity and analysis depth, typically ranging from several weeks to months. We strive to offer the swiftest turnaround without compromising quality.
Quotation and Ordering
Backed by a team of experts with extensive experience, we assure you of top-quality data and tailored outcomes to satisfy your project needs. For any additional requirements or inquiries, please feel free to reach out. Our specialists are eager to assist you in finding solutions.
Explore Other Options
For research use only. Not for any other purpose.